Interestingly, unlike mouse models of SHIP-1 and human patients with APDS, in which deregulation of this pathway impairs NK cell maturation, there was no reported effect of PTEN OE on NK cell development in the transgenic super-PTEN mouse model. This evidence concerns the gene INPP5D and activated PI3K-delta syndrome.